Global Strategy Fund OCSE:NOVO B Holdings History
Global Strategy Fund's Novo Nordisk AS Holding Summary
As of 2025-02-28, VALIC Co I held 3,483.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr315,740.00. This investment constitutes 0.25% of their stock portfolio, and VALIC Co I now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2022Q1. And since then Global Strategy Fund has made 3 purchases of OCSE:NOVO B, at an average price of kr399.85, for a total of 55,032.00 shares. In addition, there have been 10 sales at an average price of kr552.95 for 51,549.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, Global Strategy Fund's estimated gain on his OCSE:NOVO B holdings is kr7.98 Mil, reflecting a 36.24% gain to date.
Global Strategy Fund OCSE:NOVO B (kr423.90) Holding Chart
Global Strategy Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
